Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and will no longer be prescribed, driving the drugmaker's shares down nearly 3 percent.

NEXT
Topics:  eli lilly   lartruvo   cancer   drug   longer be prescribed   
BING NEWS:
  • T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need
    "Off the shelf" CAR T-cell therapies could offer a solution in chronic lymphocytic leukemia, where T-cell exhaustion creates treatment challenges. This article will appear in the May 2024 issue of ...
    04/29/2024 - 1:59 pm | View Link
  • Weight loss drugs may work for sleep apnea, Eli Lilly study finds
    The diabetes and weight loss drug tirzepatide appears to help people with obesity who also have sleep apnea, according to preliminary findings from drugmaker Eli Lilly. The results, while ...
    04/17/2024 - 12:14 am | View Link
  • Eli Lilly weight-loss drug found to address sleep apnoea in trial
    Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage ...
    04/16/2024 - 1:01 pm | View Link
  • More

 

NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More U.s. News